ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+11.31%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$311M
AUM Growth
+$311M
(+29%)
Cap. Flow
+$48.5M
Cap. Flow
% of AUM
15.58%
Top 10 Holdings %
Top 10 Hldgs %
34.58%
Holding
105
New
32
Increased
29
Reduced
26
Closed
17
Top Buys
| 1 |
Universal Health Services
UHS
|
$11.8M |
| 2 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$8.6M |
| 3 |
VWR
VWR Corporation
VWR
|
$7.23M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$6.58M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$6.49M |
Top Sells
| 1 |
STJ
St Jude Medical
STJ
|
$9.69M |
| 2 |
Encompass Health
EHC
|
$5.54M |
| 3 |
SHPG
Shire pic
SHPG
|
$4.89M |
| 4 |
McKesson
MCK
|
$4.63M |
| 5 |
Hologic
HOLX
|
$3.42M |
Sector Composition
| 1 | Healthcare | 86.32% |
| 2 | Financials | 3.19% |
| 3 | Industrials | 2.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
51
DELISTED
NEVRO CORP.
NVRO
| $1.69M | 0.54% |
18,020
+8,600
| +91% | +$806K |
|
52
Amicus Therapeutics
FOLD
$2.42B
| $1.59M | 0.51% |
223,300
-2,000
| -0.9% | -$14.3K |
|
|
AERI
53
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.51M | 0.49% |
33,330
-29,300
| -47% | -$1.33M |
|
54
Gilead Sciences
GILD
$140B
| $1.49M | 0.48% |
+22,000
| New | +$1.49M |
|
55
Eli Lilly
LLY
$661B
| $1.49M | 0.48% |
17,700
-20,400
| -54% | -$1.72M |
|
|
LUMO
56
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.43M | 0.46% |
+59,444
| New | +$1.43M |
|
57
Varex Imaging
VREX
$458M
| $1.43M | 0.46% |
+42,500
| New | +$1.43M |
|
58
Xenon Pharmaceuticals
XENE
$2.99B
| $1.36M | 0.44% |
+340,672
| New | +$1.36M |
|
|
DPLO
59
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1.36M | 0.44% |
+85,043
| New | +$1.36M |
|
60
Johnson & Johnson
JNJ
$429B
| $1.26M | 0.4% |
10,100
+1,700
| +20% | +$212K |
|
61
CONMED
CNMD
$1.64B
| $1.2M | 0.39% |
+27,100
| New | +$1.2M |
|
|
ZSAN
62
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.14M | 0.36% |
+597,180
| New | +$1.14M |
|
63
Puma Biotechnology
PBYI
$258M
| $1.1M | 0.35% |
+29,600
| New | +$1.1M |
|
|
DERM
64
DELISTED
Dermira, Inc.
DERM
| $1.06M | 0.34% |
31,188
+6,100
| +24% | +$208K |
|
65
Dynavax Technologies
DVAX
$1.19B
| $1.03M | 0.33% |
173,458
+116,658
| +205% | +$694K |
|
|
PDCO
66
DELISTED
Patterson Companies, Inc.
PDCO
| $1.01M | 0.33% |
+22,400
| New | +$1.01M |
|
|
TVTY
67
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $928K | 0.3% |
+31,900
| New | +$928K |
|
|
KERX
68
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $875K | 0.28% |
+142,100
| New | +$875K |
|
69
Prothena Corp
PRTA
$452M
| $815K | 0.26% |
+14,600
| New | +$815K |
|
|
ARA
70
DELISTED
American Renal Associates Holdings, Inc
ARA
| $776K | 0.25% |
+45,978
| New | +$776K |
|
|
ALDR
71
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $763K | 0.25% |
+36,700
| New | +$763K |
|
72
Humana
HUM
$37.5B
| $742K | 0.24% |
+3,600
| New | +$742K |
|
73
Zimmer Biomet
ZBH
$20.8B
| $716K | 0.23% |
5,864
-15,500
| -73% | -$1.89M |
|
74
Revvity
RVTY
$9.68B
| $673K | 0.22% |
+11,593
| New | +$673K |
|
|
SYNH
75
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $514K | 0.17% |
+11,200
| New | +$514K |
|